Drug
Aclarubicin clinical trials
- studies test it
- 9
- open now
- 5
- in phase 3
- 3
- first study started
- 2016
Keep track of what changes. Save the Aclarubicin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2026 (5)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 7
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 9
Shanghai Jiao Tong University School of Medicine (3) · First Affiliated Hospital of Zhejiang University (2) · Sun Yat-sen University (2) · Washington University School of Medicine (1) · The First Affiliated Hospital of Soochow University (1)
Often tested with
Tested in the same studies.
Cytarabine (5) · Homoharringtonine (3) · Granulocyte Colony-Stimulating Factor (3) · Filgrastim (3) · Lisaftoclax (2) · Daunorubicin (2) · Azacitidine (2) · Cyclophosphamide (2)
Studies
Open first, then newest update. How each study uses Aclarubicin is read from its arms, and is right about nine times in ten.
Testing it · 9
- Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationPhase 2/3First Affiliated Hospital of Zhejiang UniversityNCT07651163Written as Lisaftoclax+homoharringtonine+cytarabine+aclarubicin
- Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationPhase 2/3First Affiliated Hospital of Zhejiang UniversityNCT07651176Written as Lisaftoclax+homoharringtonine+cytarabine+aclarubicin
- Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell LymphomaNot yet recruitingPhase 2Shanghai Jiao Tong University School of MedicineNCT07535762Written as Aclarubicin
- Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell LymphomaNot yet recruitingPhase 1/2Shanghai Jiao Tong University School of MedicineNCT07535710Written as Aclarubicin
- Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid LeukemiaNot yet recruitingPhase 1/2Shanghai Jiao Tong University School of MedicineNCT07486726Written as Aclarubicin
- Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AMLStatus unknownPhase 2Sun Yat-sen UniversityNCT04254640Written as Aclarubicin
- Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral LeukodystrophyCompletedPhase 1Washington University School of MedicineNCT02723448Written as aclarubicin
- Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60Status unknownPhase 3The First Affiliated Hospital of Soochow UniversityNCT04083911Written as Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF
- Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid LeukemiaStatus unknownPhase 2Sun Yat-sen UniversityNCT03181815Written as Aclarubicin
Given in every arm · 1 — Aclarubicin is usual care beside what is tested
Codes
What other systems call Aclarubicin · ClinicalTrials.gg INT008451
- MeSH (NLM) D015250AclarubicinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 74KXF8I502ACLARUBICINConfirmed FDA, NLM, Wikidata
- RxNorm 239Confirmed FDA, Wikidata
- Wikidata Q4674302aclarubicinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C202AclarubicinConfirmed FDA, Wikidata
- DrugBank DB11617One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015250 | Aclarubicin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 74KXF8I502 | ACLARUBICIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 239 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4674302 | aclarubicin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C202 | Aclarubicin | Confirmed FDA, Wikidata |
| DrugBank | DB11617 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.